Article Information
History
- September 23, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 23, 2021 - 15:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sarah E. Briggs1,†,
- Philip Law2,
- James E. East3,4,
- Sarah Wordsworth4,5,
- Malcolm Dunlop6,
- Richard Houlston2,
- Julia Hippisley-Cox7,* and
- Ian Tomlinson8,*,†
- 1Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 2Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- 3Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 4NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
- 5Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 6Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
- 7Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 8Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
- ↵†Corresponding Authors:
sarah.briggs{at}ndm.ox.ac.uk; ian.tomlinson{at}igmm.ed.ac.uk
↵* these authors contributed equally
Posted September 23, 2021.
Integrating genome-wide polygenic risk scores and non-genetic risk factors to develop and validate risk prediction models for colorectal cancer
